An internally controlled peripheral biomarker for Alzheimer’s disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin
Author of publication
Tapan K. Khan and Daniel L. Alkon
Date of publication
29/08/2006
Download
RW-Admin
Association of Cognitive Function Trajectories in Centenarians With Postmortem Neuropathology, Physical Health, and Other Risk Factors for Cognitive Decline
Prev post
PKC Deficits in Alzheimer’s Disease Brains and Skin Fibroblasts
Next post
Search for:
Recent Posts
ISPOR Annual Conference: 90% of Physicians Follow Results of DISCERN, First Skin Test for Alzheimer’s Disease
May is Older Americans Month: Definitive Diagnosis of Alzheimer’s Disease Helps More Americans Get the Support They Need Sooner
SYNAPS Dx Joins American Brain Coalition, Advocates for More Research, Better Treatment and Support for People with Brain Disorders
Semler Scientific Investment Advances Market Positioning and Confidence in SYNAPS Dx
DISCERN™ Video Showcases Benefits of First Accurate, Autopsy-Confirmed Test for Alzheimer’s Disease
Recent Comments
Archives
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
October 2019
September 2019
December 2018
November 2018
Categories
Uncategorized
Meta
Log in
Entries feed
Comments feed
WordPress.org
Input your search keywords and press Enter.
Recent Comments